Skip to main content
Premium Trial:

Request an Annual Quote

Advion Reaches OEM, Distribution Deal with CAMAG for TLC/MS Interface Product

NEW YORK (GenomeWeb News) – Advion said on Monday it has signed an exclusive original equipment manufacturing and distribution partnership deal with Swiss firm CAMAG for Advion's TLC/MS interface product.

The two companies plan to commercialize a combined system to Advion's Synthetic Organic Chemistry and Peptide Synthesis global market segments, Advion said, adding it has exclusive marketing and support rights in certain geographies, including North America and parts of Europe.

"TLC is used in reaction monitoring, flash method development … solvent selection, flash fraction confirmation, and impurity profiling," David Patteson, CEO of Advion, said in a statement. "The combination of the CAMAG TLC-MS Interface with the Advion expression CMS is a perfect integration of best-in-class chemist assay tools."

The expression compact mass spectrometer is targeted for the discovery research and process development synthetic organic chemistry market and can provide rapid compound confirmation in normal phase chromatography fractions.

Advion plans to launch the combined system at conferences in March and April, the Ithaca, NY-based company said.

Financial and other terms of the deal were not disclosed.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.